4Steven B, Juhani E, Claire -Anne S, et al. Importance of background rates of disease in assessment of vaccine safety during mass immunization with pandemic H1Nlinfluenza vaccines [J]. Public Health, 2009, 6736 (9): 61877-61878.
5PAHO / WHO . Immunization safety : How to address events allegedly attribute to vaccination or immunization [ Z ]. 2002.
